Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
Akinobu Takaki(Okayama University), Kazuhide Yamamoto(Kurume University Medical Center), Kazuhiro Nouso(Okayama Prefecture), Masashi Utsumi(Okayama University), Hidenori Shiraha(Kawasaki Medical School), Tetsuya Yasunaka(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Yuko Yasuda(Okayama University Hospital), Yasuhiro Miyake(High Energy Accelerator Research Organization), Toshiyoshi Fujiwara(Okayama University), Fusao Ikeda(Okayama University), Susumu Shinoura(Okayama University), Daisuke Sato(Okayama University), Takahito Yagi(Okayama University), Eiichi Nakayama(Kawasaki University of Medical Welfare), Yuzo Umeda(Okayama University), Hiroshi Sadamori(Okayama University), Ryuichi Yoshida(Okayama University)
Cited by 17
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
A new approach for measuring the muon anomalous magnetic moment and electric dipole moment
|Progress of Theoretical and Experimental Physics|2019|239